Benign prostatic hyperplasia epidemiology and demographics

Revision as of 21:16, 30 September 2012 by Shankar Kumar (talk | contribs)
Jump to navigation Jump to search

Benign prostatic hyperplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Benign Prostatic Hyperplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Benign prostatic hyperplasia epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Benign prostatic hyperplasia epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Benign prostatic hyperplasia epidemiology and demographics

CDC on Benign prostatic hyperplasia epidemiology and demographics

Benign prostatic hyperplasia epidemiology and demographics in the news

Blogs on Benign prostatic hyperplasia epidemiology and demographics

Directions to Hospitals Treating Benign prostatic hyperplasia

Risk calculators and risk factors for Benign prostatic hyperplasia epidemiology and demographics

Steven C. Campbell, M.D., Ph.D.

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Epidemiology and Demographics

More than half of the men in the United States between the ages of 60 and 70 and as many as 90% between the ages of 70 and 90 have symptoms of BPH. For some men, the symptoms may be severe enough to require treatment.

References

Template:WH Template:WS